Effect of rifampicin on metoprolol and antipyrine kinetics. - Wikidata - wikimedia - TriplyDB

Effect of rifampicin on metoprolol and antipyrine kinetics.

Effect of rifampicin on metoprolol and antipyrine kinetics.

http://www.wikidata.org/entity/Q41957240

about

Prediction of metabolic drug interactions involving beta-adrenoceptor blocking drugs Pharmacokinetics of antipyrine in epileptic patients Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies.Pharmacokinetics and interactions of headache medications, part II: prophylactic treatments.Rifampicin and anti-hypertensive drugs in chronic kidney disease: Pharmacokinetic interactions and their clinical impact.Pharmacokinetic interaction between rifampin and zidovudine.Two- and four-day rifampin chemoprophylaxis regimens induce oxidative metabolism.Induction of mixed function oxidase activity in man by rifapentine (MDL 473), a long-acting rifamycin derivative Enzyme induction and beta-adrenergic receptor blocking drugs.Drug interactions and beta blockers.Unexpected effect of rifampin on the pharmacokinetics of linezolid: in silico and in vitro approaches to explain its mechanism.Induction of propranolol metabolism by rifampicin.Interaction of tertatolol with rifampicin and ranitidine pharmacokinetics and antihypertensive activity.

P2860

Q28365793-F2318B71-90BE-47E6-B7FD-2F361BACB224 Q34447648-9871AC59-FD99-4FA8-9E44-3DDB3648531A Q34621602-0B765A36-851B-4495-A855-D1B2016845C6 Q35030873-2B30698F-5C4C-49E8-B072-BA416A637E42 Q36662893-31898DCA-630A-43B1-9D63-47369A3B9183 Q37241076-85BC0F38-3536-43D2-A81F-125DFDC49AB3 Q39866285-E9386653-F317-4FC6-BD8A-61928673A149 Q39879718-CD2444BD-7A61-4D58-BE4E-3F5BEF12D01A Q41836161-BC227179-01F7-4831-9EBD-0393279B12C5 Q41987008-CEBA77B1-7459-40E8-8451-73EAD41B536F Q42118325-83979577-2BC0-4402-BE3C-790A4008AAE5 Q42655585-E3603876-14D6-4EF1-9C67-0FFB73C26E93 Q43262011-5E229587-F899-4C81-B098-B5F323180ABA Q43595870-A5CC50BA-E611-4078-8ACC-73561775871B

P2860

Effect of rifampicin on metoprolol and antipyrine kinetics.

http://www.wikidata.org/entity/Q41957240

description

1982 nî lūn-bûn

@nan

1982年の論文

@ja

1982年論文

@yue

1982年論文

@zh-hant

1982年論文

@zh-hk

1982年論文

@zh-mo

1982年論文

@zh-tw

1982年论文

@wuu

1982年论文

@zh

1982年论文

@zh-cn

name

Effect of rifampicin on metoprolol and antipyrine kinetics.

@en

type

label

Effect of rifampicin on metoprolol and antipyrine kinetics.

@en

prefLabel

Effect of rifampicin on metoprolol and antipyrine kinetics.

@en

P1433

Q41957240-27E71EE2-AF26-4AF7-BA95-D39B75E510F8

P1476

Q41957240-75CC243E-590F-442B-ABD3-9FFF7AEBDCEF

P2093

Q41957240-63D5ED36-8929-4676-8CA7-0D079130C76E

Q41957240-9F38310D-033C-4839-A841-52050A2C2657

Q41957240-FDFA84C3-7F45-440A-898B-A6149890AD81

P2860

Q41957240-1CBE06D7-1220-4832-87EB-FE8321FFA14A

Q41957240-1D516A1F-FE15-41E3-A491-5A27B98302AE

Q41957240-6338BDF1-6E0E-482F-8FAD-6BB81DA4A6AD

Q41957240-68C4EDAA-8D8E-4BA5-ACC5-43C032BC736F

Q41957240-AF7E8792-7B33-495E-BEC8-56BFAC56B985

Q41957240-C07BD94B-F805-4406-A618-F358839B5160

Q41957240-C3F7AC93-8A75-4E5B-9F7F-CFBBD42B85C5

Q41957240-E29BF84E-77A6-481C-AD95-BF2E8DC245DA

P304

Q41957240-6FB63C89-D290-4201-B1FB-84EBB3F660B2

P31

Q41957240-7291B48E-824F-4096-B235-5951F800B1DD

P356

Q41957240-FDDC443E-EE25-4ACA-8E18-383F692B4794

P407

Q41957240-84A2992F-F8D5-4354-9100-D200441299F2

P433

Q41957240-7B90CCBE-0A54-4372-9CEB-F1C0E3A97078

P478

Q41957240-C8B0A05B-E208-4A9F-A5DB-9C54CFD5D59D

P577

Q41957240-48F2B078-0C1E-4125-BC09-331994237D7C

P5875

Q41957240-F3878B8E-432A-4030-ABBC-F986AFCE753D

P698

Q41957240-10B8D740-9901-48D8-B713-9406362B9F65

P932

Q41957240-ADBA7258-8226-4585-A4AC-125009BA866C

P356

J.1365-2125.1982.TB01390.X

P1433

British Journal of Clinical Pharmacology

P1476

Effect of rifampicin on metoprolol and antipyrine kinetics.

@en

P2093

Bennett PN

http://www.w3.org/2001/XMLSchema#string

John VA

http://www.w3.org/2001/XMLSchema#string

Whitmarsh VB

http://www.w3.org/2001/XMLSchema#string

P2860

Influence of route of administration on drug availability.

Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.

Induction of hepatic microsomal enzymes after brief administration of rifampicin in man.

Influence of pentobarbital on metoprolol plasma levels.

Commentary: a physiological approach to hepatic drug clearance.

Metabolism of metoprolol in the rat in vitro and in vivo.

Comparative bioavailability and effect studies on metoprolol administered as ordinary and slow-release tablets in single and multiple doses.

Differential induction of antipyrine metabolism by rifampicin.

P304

387-391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.1982.TB01390.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

1982-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

16140484

http://www.w3.org/2001/XMLSchema#string

P698

7059439

http://www.w3.org/2001/XMLSchema#string

P932

1402102

http://www.w3.org/2001/XMLSchema#string